To provide an updated assessment of the efficacy-safety profile of very short (1 or 3 months) dual antiplatelet therapy (DAPT) compared to long (12 months) DAPT in patients undergoing percutaneous coronary interventions (PCI).
Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials
Benenati, Stefano;De Marzo, Vincenzo;Canepa, Marco;Ameri, Pietro;Porto, Italo
2020-01-01
Abstract
To provide an updated assessment of the efficacy-safety profile of very short (1 or 3 months) dual antiplatelet therapy (DAPT) compared to long (12 months) DAPT in patients undergoing percutaneous coronary interventions (PCI).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
pvaa001.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
776.85 kB
Formato
Adobe PDF
|
776.85 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
